Bionano Genomics (BNGO) Change in Cash (2017 - 2026)

Bionano Genomics has reported Change in Cash for 10 years, with the latest figure at $403000.0 in Q1 2026.

• Quarterly Change in Cash rose 106.78% year-over-year to $403000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 110.27% YoY) and the FY2025 annual result came in at -$5.1 million, up 42.29% from the prior year.
• Change in Cash fell to $403000.0 in Q1 2026 per BNGO's latest filing, from $1.4 million in the prior quarter.
• Over five years, Change in Cash peaked at $19.7 million in Q3 2023 and troughed at -$22.7 million in Q4 2022.
• A 5-year average of -$1.2 million and a median of -$63000.0 in 2025 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2025: Change in Cash surged 1857.5% in 2023, then sank 171.72% in 2025.
• Over 5 years, Change in Cash stood at -$22.7 million in 2022, then advanced by 26.7% to -$16.6 million in 2023, then soared by 102.28% to $379000.0 in 2024, then soared by 281.0% to $1.4 million in 2025, then plunged by 72.09% to $403000.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $403000.0, $1.4 million, and -$497000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.